Your browser doesn't support javascript.
COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information.
Mauri, Davide; Kamposioras, Konstantinos; Tsali, Lampriani; Dambrosio, Mario; De Bari, Berardino; Hindi, Nadia; Salembier, Carl; Nixon, Joanna; Dimitrios, Tzachanis; Alongi, Flippo; Hameed, Hassan; Valachis, Antonios; Papadimitriou, Konstantinos; Corradini, Stefanie; Popovic, Lazar; Kopecky, Jindrich; Rodriguez, Andres; Antunac, Katarina; Yi, Junlin; Lovey, Jozsef; Strojan, Primoz; Saraireh, Haytham; Røtterud, Ranveig; Chojnacka, Marzanna; Olalla, Santa Cruz; Chilingirova, Natalia; De Mello, Ramon Andrade; Amaral, Giovanna Araujo; Arbabi, Farsid; Vidra, Radu; Rapushi, Erjeta; Takeuchi, Dan; Christopoulos, Chirstos; Ivanova, Irina; Djan, Igor; Petricevic, Branka; Cellini, Francesco; Mihaylova, Iglika; Plavetic, Natalija Dedic; Kuhar, Cvetka Grasic; Takeuchi, Elena; Kountourakis, Pantelis; Ntellas, Panagiotis; Gazouli, Ioanna; Gkoura, Stefania; Yuce, Salih; Er, Özlem; Yasmina, Chait; Kumaran, Gireesh; Spahiu, Orges.
  • Mauri D; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Kamposioras K; Department. Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Tsali L; PACMeR Evidence Based Medicine, Athens, Greece.
  • Dambrosio M; Department. Medical Oncology, Clinica San Carlo, Paderno Dugnano, Milano Italy.
  • De Bari B; Service Radio-Oncologie Neuchâtel Hôpital Network, La Chaux-de-Fonds, Switzerland.
  • Hindi N; Department. Medical Oncology, Fundación Jimenez Díaz University Hospital, Madrid, Spain.
  • Salembier C; Radiation Oncology Department, Europe Hospitals, Brussels, Belgium.
  • Nixon J; Beatson West of Scotland Cancer Center, Strathclyde University, Glasgow, UK.
  • Dimitrios T; UCSD Blood and Marrow Transplant Program, UCSD/Moores Cancer Center, La Jolla, CA, USA.
  • Alongi F; Advanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria, Negrar-Verona,University of Brescia, Verona, Italy.
  • Hameed H; The Christie NHS Foundation Trust, Manchester UK, The Christie\'s Hospital, Manchester, UK.
  • Valachis A; Department Medical Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Antonios, Sweden.
  • Papadimitriou K; Department of Medical Oncology, University Hospital of Antwerp, Antwerp, Belgium.
  • Corradini S; Department Radiation Oncology, University Hospital, LMU Munich, Germany.
  • Popovic L; Department Medical Oncology,Oncology Institute of Vojvodina, University of Novi Sad, Serbia.
  • Kopecky J; Department Oncology and Radiotherapy, Charles University, Hradec Králové, Prague, Czech Republic.
  • Rodriguez A; Medical Oncology, Instituto Alexander Fleming in Buenos Aires, Buenos Aires, Argentina.
  • Antunac K; University Hospital for Tumors, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia.
  • Yi J; Department Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Lovey J; National Institute of Oncology, Semmelweis University, Budapest, Hungary.
  • Strojan P; Department Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia.
  • Saraireh H; Department Radiation Oncology, Royal Medical Service, Amman, Jordan.
  • Røtterud R; Cell Biologist, CEO Bladder Cancer, Oslo, Norway.
  • Chojnacka M; Department of Oncology and Radiotherapy, Maria Sklodowska- Curie National Research Institute of Oncology, Warsaw, Poland.
  • Olalla SC; Service de Radio-Oncologie, Neuchâtel Hôpital Network, La Chaux-de-Fonds, Switzerland.
  • Chilingirova N; Department Medical Oncology, Center of Excellence, Heart and Brain Hospital Pleven, Medical University Pleven, Bulgaria.
  • De Mello RA; Department Medical Oncology Escola Paulista de Medicina, Federal University of São Paulo, Brazil.
  • Amaral GA; Department Biomedical Sciences,and Medicine, University of Algarve, Faro, Portugal.
  • Arbabi F; Department Medical Oncology, Escola Paulista de Medicina, Federal University of São Paulo, Brazil.
  • Vidra R; Department Medical Oncology, Rooshana Cancer Center, Tehran, Iran.
  • Rapushi E; Medical Oncology, Regional Institute of Gastroenterology and Hepatology "Prof. Dr. O. Fodor", Cluj-Napoca, Romania.
  • Takeuchi D; Department Medical Oncology, Berat Regional Hospital, Berat, Albania.
  • Christopoulos C; Matsudo City General Hospital, Chiba, Japan.
  • Ivanova I; Service de Radiothérapie Oncologique, GHT Grand Paris Nord-Est. G.H.I Le Raincy -Montfermeil, France.
  • Djan I; Murmansk Branch of All-Russian Association of Cancer Patients "Zdravstvuy", NGO Center of Initiatives Support, Murmansk, Russia.
  • Petricevic B; Department for Radiosurgery and SBRT, Clinical center of Serbia, Belgrade, Serbia.
  • Cellini F; Department of Medical Oncology and Hematology,Wilhelminenspital, Vienna, Austria.
  • Mihaylova I; Radioterapia Oncologica-Fondazione Policlinico A. Gemelli, IRCCS -Rome, Italy.
  • Plavetic ND; Department of Radiotherapy,Specialized Hospital for Active Treatment in Oncology "Plovdivsko pole", Sofia, Bulgaria.
  • Kuhar CG; Department of Oncology, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia.
  • Takeuchi E; Department Medical Oncology, Institute of Oncology, Ljubljana, Slovenia.
  • Kountourakis P; The Christie NHS Foundation Trust, Manchester, UK.
  • Ntellas P; Department Medical Oncology,Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  • Gazouli I; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Gkoura S; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Yuce S; Department Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Er Ö; Chairmen of the Board-Young Saving Association, Turkey.
  • Yasmina C; Acibadem University, Faculty of Medicine, Turkey.
  • Kumaran G; Service de Haematologie, GHT Grand Paris Nord-Est. G.H.I Le Raincy -Montfermeil, France GHT Grand Paris Nord-Est, G.H.I Le Raincy -Montfermeil, France.
  • Spahiu O; Medical Oncology, Auckland Regional Cancer and Blood Service, Auckland, New Zealand.
Rev Recent Clin Trials ; 17(1): 11-14, 2022.
Article in English | MEDLINE | ID: covidwho-1592690
ABSTRACT

BACKGROUND:

Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and death from COVID-19 and need vaccination guidance and support. Guidance availability in the English language only is a major limit for recommendations' delivery and their application in the world's population and generates information inequalities across the different populations.

METHODS:

Most of the available COVID-19 vaccination guidance for cancer patients was screened and scrutinized by the European Cancer Patients Coalition (ECPC) and an international oncology panel of 52 physicians from 33 countries.

RESULTS:

A summary guidance was developed and provided in 28 languages in order to reach more than 70 percent of the global population.

CONCLUSION:

Language barrier and e-guidance availability in the native language are the most important barriers when communicating with patients. E-guidance availability in various native languages should be considered a major priority by international medical and health organizations that are communicating with patients at the global level.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Recent Clin Trials Journal subject: Medicine / Therapeutics Year: 2022 Document Type: Article Affiliation country: 1574887116666211028145848

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Recent Clin Trials Journal subject: Medicine / Therapeutics Year: 2022 Document Type: Article Affiliation country: 1574887116666211028145848